StartupHubOpportunity: Treating Cancers with Novel Therapeutics that Mediate Proliferative Signaling скачать в хорошем качестве

StartupHubOpportunity: Treating Cancers with Novel Therapeutics that Mediate Proliferative Signaling

Innovations in therapeutic development are transforming how we treat aggressive cancers and vascular lung diseases such as lung cancer and pulmonary arterial hypertension. Our newly discovered class of therapeutics targets a previously unidentified protein-protein interaction that drives pathological cell proliferation, enabling a highly selective approach that slows disease progression while sparing healthy cells. In preclinical studies, these compounds demonstrated strong anti-proliferative activity and protective effects without observed toxicity. By focusing on precision targeting and disease-specific mechanisms, this platform has the potential to improve treatment effectiveness, reduce side effects, and enhance quality of life for patients facing life-threatening conditions. Join us in advancing next-generation therapeutics that aim to deliver safer, more effective treatment options for patients in need. This opportunity features Olga Rafikova, MD, PhD, Associate Professor, Medicine at the College of Medicine – Tucson at the University of Arizona, inventor and scientific lead behind the technology. View this and other high-potential technologies on the Tech Launch Arizona StartupHub.